Compare drug product CDMOs for formulation development, solid oral dosage, sterile injectables, and specialty dosage forms. Filter by dosage type, scale, and certifications.
1365 companies listed
Drug product manufacturing transforms active pharmaceutical ingredients into the finished dosage forms patients use. This includes solid oral dosage (tablets, capsules), sterile injectables (vials, pre-filled syringes), semi-solids (creams, gels), and specialty forms (transdermal patches, inhalers, implants).
Formulation development is where science meets engineering. A CDMO's formulation team determines bioavailability, stability, and manufacturability. For poorly soluble compounds, techniques like spray drying, hot melt extrusion, and nano-milling can be the difference between a viable product and a failed program. Ask for specific experience with your compound class.
What scale do you need? Clinical-phase drug product often runs in batches of 5,000-50,000 units. Commercial scale might mean millions of units per month. Few CDMOs cover the full range efficiently. Match your current and projected volumes to a CDMO with the right equipment and batch size flexibility.
Germany
Acnos Pharma GmbH is a privately-owned German pharmaceutical company specializing in global clinical trial supply, packaging, and logistics. They provide clinical trial materials management, supply chain coordination, and patient-centric delivery services. They do not manufacture drugs but manage the supply chain for clinical trials.
China
ACROBiosystems is a cornerstone enterprise of the global biopharma industry, providing recombinant proteins, antibodies, cell lines, cell culture reagents (including GMP-grade growth factors), assay kits, and critical reagents for drug discovery through clinical manufacturing. They supply raw materials and tools for the pharmaceutical and biotech industry but do not manufacture drugs for other companies.
Our AI Matchmaker analyzes your project requirements and matches you with qualified manufacturing partners. Free for buyers.
Canada
Acuitas Therapeutics is a Canadian biotechnology company and the global leader in lipid nanoparticle (LNP) delivery technology. Their LNP technology is used in two approved products (ONPATTRO and COMIRNATY). They operate on a strategic partnership model, licensing their LNP platform to pharma and biotech partners rather than manufacturing drugs. They do not function as a CDMO; they are a technology platform company that partners with CDMOs for manufacturing.